In This Article:
Novo Nordisk has terminated a collaboration agreement with Hims & Hers, accusing the telehealth company of "failing to adhere to the law" regarding compounded weight loss drug sales.
With the alliance launched only in April, the Danish drugmaker’s move brings a swift end…